Strata Critical Medical, Inc. Segments Disclosure
| For the Years Ended | |||||||||||
| December 31, 2025 | December 31, 2024 | ||||||||||
| Logistics: | |||||||||||
| Revenue | $ | 176,793 | $ | 146,817 | |||||||
| Cost of revenue | 140,162 | 117,228 | |||||||||
| Gross profit | $ | 36,631 | $ | 29,589 | |||||||
| Clinical: | |||||||||||
| Revenue | $ | 20,348 | $ | — | |||||||
| Cost of revenue | 15,853 | — | |||||||||
| Gross profit | $ | 4,495 | $ | — | |||||||
| Consolidated: | |||||||||||
| Revenue | $ | 197,141 | $ | 146,817 | |||||||
| Cost of revenue | 156,015 | 117,228 | |||||||||
| Gross profit | $ | 41,126 | $ | 29,589 | |||||||
| Reconciliation: | |||||||||||
| For the Years Ended | |||||||||||
| December 31, 2025 | December 31, 2024 | ||||||||||
| Gross profit | $ | 41,126 | $ | 29,589 | |||||||
| Less: | |||||||||||
Selling, general and administrative | 60,875 | 50,856 | |||||||||
Amortization of intangible assets | 2,604 | 1,258 | |||||||||
| Operating loss from continuing operations | (22,353) | (22,525) | |||||||||
| Less: | |||||||||||
| Interest income | 4,241 | 7,214 | |||||||||
| Change in fair value of warrant liabilities | 4,278 | (850) | |||||||||
| Change in fair value of assets and other liabilities | (1,037) | — | |||||||||
| Realized loss from sales of short-term investments | (5,195) | — | |||||||||
| Loss from continuing operations before income taxes | $ | (20,066) | $ | (16,161) | |||||||
| December 31, 2025 | December 31, 2024 | ||||||||||
| Goodwill | |||||||||||
| Logistics | $ | 15,540 | $ | 15,540 | |||||||
| Clinical | 72,670 | — | |||||||||
| Total Goodwill | $ | 88,210 | $ | 15,540 | |||||||
Want the next Strata Critical Medical, Inc. segments disclosure the moment it drops?
Set a Sentinel and we'll alert you the moment Strata Critical Medical, Inc.'s next filing hits EDGAR. No credit card, your email never gets sold.
Historical Timeline
| Fiscal Year | Filed | |
|---|---|---|
| 2025 | Mar 3, 2026 | Showing above |
| 2024 | Mar 13, 2025 | |
| 2023 | Mar 12, 2024 | |
| 2022 | Mar 16, 2023 | |
About Segments Disclosures
Segment disclosures break a company into its reportable operating units, revealing revenue, profit, and asset allocation that consolidated financial statements obscure. Under ASC 280, segments must match how the chief operating decision maker views the business, providing a window into internal management structure and resource allocation priorities.
Key signals: compare segment margins to identify which units drive profitability and which destroy value. Watch for changes in the number of reportable segments — segment aggregation or disaggregation often coincides with strategic shifts or attempts to obscure declining performance. Intersegment elimination patterns reveal internal pricing practices. The reconciliation between segment totals and consolidated figures exposes corporate overhead allocation and unallocated items. Geographic revenue concentration highlights regulatory and currency exposure. Compare segment-level capital expenditure against segment revenue to assess where management is investing for future growth versus harvesting existing assets.